We are studying the safety and long-term effectiveness of faricimab injections for people with neovascular age-related macular degeneration. The goal is to see if it improves vision and how well it works over time.
Health conditions and diseases that the clinical trial is designed to study and treat.
Neovascular Age-Related Macular Degeneration (nAMD) is a serious eye condition that leads to vision loss due to abnormal blood vessel growth in the retina, primarily affecting older adults. It can cause symptoms like blurred vision, dark spots in the central vision, and difficulty seeing in low light.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
